ERC-AG-LS6
ERC-AG-LS6
Programme: H2020
69 projects · €151,631,416 total EU contribution (project-level) · 60 participating organizations · 19 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€151,631,416
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (14)
- UK (8)
- CH (6)
- France (6)
- Italy (5)
- Spain (4)
- Netherlands (3)
- IL (2)
- AT (1)
- BE (1)
- CA (1)
- DK (1)
- EL (1)
- FI (1)
- HR (1)
- IE (1)
- NO (1)
- PT (1)
- ZA (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- IP5 projects · FR
- CNRS3 projects · FR
- INSERM3 projects · FR
- UOXF3 projects · UK
- GERMAN CANCER RESEARCH CENTER2 projects · DE
- ETH Zürich2 projects · CH
- IRB2 projects · CH
- HUMANITAS MIRASOLE SPA2 projects · IT
- INSTITUT CURIE FONDATION2 projects · FR
- MPG2 projects · DE
- MRC2 projects · UK
- NKI AVL2 projects · NL
Projects
Page 2 of 7
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
The humoral innate immune system: long pentraxins as a paradigm HIIS · 233417 | FP7 | €2,066,200 | €2,066,200 | Details |
Lymph node homing of immune cells via afferent lymphatics – mechanisms and immune response LYMPHATICS-HOMING · 322645 | FP7 | €2,491,200 | €2,491,200 | Details |
Gut immunity and homeostasis in Drosophila GUTDROSO · 233346 | FP7 | €1,485,627 | €1,485,627 | Details |
The influence of Aryl hydrocarbon receptor ligands on protective and pathological immune responses AHRIMMUNITY · 232782 | FP7 | €1,242,352 | €1,242,352 | Details |
Immunogenetics of Severe Bacterial Disease Susceptibility and Vaccine Responses in Humans IMMUNOGENE · 294557 | FP7 | €1,997,927 | €1,997,927 | Details |
Development and differentiation of CD8 T lymphocytes CD8 T CELLS · 233036 | FP7 | €1,969,644 | €1,969,644 | Details |
Functional Role of the HLA-DR15 Haplotype in Multiple Sclerosis HLA-DR15 in MS · 340733 | FP7 | €2,368,068 | €2,368,068 | Details |
Thymopoiesis: From Evolutionary Origins to Future Therapies EVOTHYME · 323126 | FP7 | €2,496,900 | €2,496,900 | Details |
Mesenchymal Cells of the Lamina Propria in Intestinal Epithelial and Immunological Homeostasis MCs-inTEST · 340217 | FP7 | €2,590,000 | €2,590,000 | Details |
New approaches to analyze and exploit the human B and T cell response against viruses IMMUNEXPLORE · 250348 | FP7 | €1,979,200 | €1,979,200 | Details |